RARE CELL ANALYSIS BY MULTI-SPECTRAL FLOW IMAGING

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$124,380.00
Award Year:
2002
Program:
SBIR
Phase:
Phase I
Contract:
1R43CA094590-01
Award Id:
59945
Agency Tracking Number:
CA094590
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
AMNIS CORPORATION, 2505 3RD AVE, STE 210, SEATTLE, WA, 98121
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
DAVID BASIJI
(206) 374-7165
BASIJI@AMNIS.COM
Business Contact:
DAVID BASIJI
(206) 576-6857
BASIJI@AMNIS.COM
Research Institute:
n/a
Abstract
The ability to detect and analyze rare malignant cells in body fluids has profound implications for the early detection of malignancy as well as for monitoring of residual disease and metastases. Current methodologies for accurately detecting abnormal cells within a population of normal cells are limited. Amnis' ImageStream technology combines the high-resolution imaging performance of microscopy and the high-speed cellular analysis and sorting capabilities of flow cytometry in a single platform. ImageStream employs time delay integration detection, resulting in up to a 1000 fold increase in signal collection over conventional instrument designs. The goal of this Phase I study is to optimize algorithms, electronics, and assays for the detection and analysis of rare exfoliated cells in body fluids. The image segmentation algorithm will be redesigned to operate with brightfield imagery as well as fluorescence and implemented on high-speed image computing hardware. A morphological feature set will be developed to discriminate epithelial cells. Ultimately, it is expected that instrumentation based on ImageStream technology will find application in the biological research laboratory, drug discovery arena, and in the clinical setting as a screening system for he early detection of cancer. PROPOSED COMMERCIAL APPLICATIONS: Amnis' ImageStream technology represents an entirely new class of cellular analysis instrumentation with numerous opportunities for commercialization. It is expected that ImageStream will find application in drug discovery, biological research, genomics and proteomics, non- invasive prenatal diagnostics and early-stage cancer detection.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government